共 50 条
Recent advances in the design of small molecular drugs with acrylamides covalent warheads
被引:2
|作者:
Liang, Luxia
[1
,2
,3
]
Zhang, Ze
[1
,2
,3
]
You, Qidong
[1
,2
,3
]
Guo, Xiaoke
[1
,2
,3
]
机构:
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Peoples R China
[3] China Pharmaceut Univ, Sch Pharm, Dept Med Chem, Nanjing 210009, Peoples R China
基金:
中国国家自然科学基金;
关键词:
Acrylamide;
Covalent warhead;
Small molecular drug;
Inhibitors;
GROWTH-FACTOR RECEPTOR;
BRUTONS TYROSINE KINASE;
IRREVERSIBLE INHIBITORS;
JAK3;
INHIBITORS;
DISCOVERY;
CANCER;
INACTIVATION;
QUINAZOLINE;
REACTIVITY;
STRATEGY;
D O I:
10.1016/j.bmc.2024.117902
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
In the development of covalent inhibitors, acrylamides warhead is one of the most popular classes of covalent warheads. In recent years, researchers have made different structural modifications to acrylamides warheads, resulting in the creation of fluorinated acrylamide warheads and cyano acrylamide warheads. These new warheads exhibit superior selectivity, intracellular accumulation, and pharmacokinetic properties. Additionally, although ketoamide warheads have been applied in the design of covalent inhibitors for viral proteins, it has not received sufficient attention. Combined with the studies in kinase inhibitors and antiviral drugs, this review presents the structural features and the progression of acrylamides warheads, offering a perspective on future research and development in this field.
引用
收藏
页数:13
相关论文